Badrinath Konety
Badrinath Konety
Professor, Urology, University of Minnesota
Verified email at
Cited by
Cited by
Early detection of prostate cancer: AUA Guideline
HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ...
The Journal of urology 190 (2), 419-426, 2013
Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline
SS Chang, SA Boorjian, R Chou, PE Clark, S Daneshmand, BR Konety, ...
The Journal of urology 196 (4), 1021-1029, 2016
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
DJ Parekh, IM Reis, EP Castle, ML Gonzalgo, ME Woods, RS Svatek, ...
The Lancet 391 (10139), 2525-2536, 2018
Active surveillance for the management of prostate cancer in a contemporary cohort
MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results …
BR Konety, SA Joslyn, MA O’DONNELL
The Journal of urology 169 (3), 946-950, 2003
Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer
SA Joslyn, BR Konety
Urology 68 (1), 121-125, 2006
Oral relugolix for androgen-deprivation therapy in advanced prostate cancer
ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ...
New England Journal of Medicine 382 (23), 2187-2196, 2020
Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes
PK Agarwal, N Sadetsky, BR Konety, MI Resnick, PR Carroll
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Recurrence of high‐risk bladder cancer: a population‐based analysis
K Chamie, MS Litwin, JC Bassett, TJ Daskivich, J Lai, JM Hanley, ...
Cancer 119 (17), 3219-3227, 2013
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
AV Balar, AM Kamat, GS Kulkarni, EM Uchio, JL Boormans, M Roumiguié, ...
The Lancet Oncology 22 (7), 919-930, 2021
PSA screening among elderly men with limited life expectancies
LC Walter, D Bertenthal, K Lindquist, BR Konety
Jama 296 (19), 2336-2342, 2006
Complications after radical cystectomy: analysis of population-based data
BR Konety, V Allareddy, H Herr
Urology 68 (1), 58-64, 2006
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy
J Kurhanewicz, DB Vigneron, SJ Nelson, H Hricak, JM MacDonald, ...
Urology 45 (3), 459-466, 1995
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ...
The Lancet Oncology 22 (1), 107-117, 2021
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
RH Getzenberg, BW Light, PE Lapco, BR Konety, AK Nangia, JS Acierno, ...
Urology 50 (6), 999-1006, 1997
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami, H Shiina, H Enokida, T Kawakami, T Tokizane, T Ogishima, ...
Clinical Cancer Research 12 (2), 383-391, 2006
Bladder cancer-associated nuclear matrix proteins
RH Getzenberg, BR Konety, TA Oeler, MM Quigley, A Hakam, MJ Becich, ...
Cancer Research 56 (7), 1690-1694, 1996
Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project
BR Konety, V Dhawan, V Allareddy, SA Joslyn
The Journal of urology 173 (5), 1695-1700, 2005
Urine based markers of urological malignancy
BR Konety, RH Getzenberg
The Journal of urology 165 (2), 600-611, 2001
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey
CH Bunker, AL Patrick, BR Konety, R Dhir, AM Brufsky, CA Vivas, ...
Cancer Epidemiology Biomarkers & Prevention 11 (8), 726-729, 2002
The system can't perform the operation now. Try again later.
Articles 1–20